X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Cipla - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs CIPLA - Comparison Results

CIPLA 
   Change

Cipla is one of the largest pharma companies in the domestic market and has presence in formulations and bulk drugs manufacturing. All the bulk drug manufacturing facilities of the company have been approved by various authorities including the US FD... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE CIPLA TTK HEALTHCARE/
CIPLA
 
P/E (TTM) x 29.6 43.6 67.8% View Chart
P/BV x 5.4 3.6 151.6% View Chart
Dividend Yield % 0.5 0.4 149.3%  

Financials

 TTK HEALTHCARE   CIPLA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
CIPLA
Mar-17
TTK HEALTHCARE/
CIPLA
5-Yr Chart
Click to enlarge
High Rs663622 106.7%   
Low Rs399458 87.1%   
Sales per share (Unadj.) Rs535.6181.9 294.5%  
Earnings per share (Unadj.) Rs15.912.9 123.9%  
Cash flow per share (Unadj.) Rs20.029.3 68.3%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Dividend yield (eoy) %0.80.4 203.4%  
Book value per share (Unadj.) Rs137.6155.7 88.4%  
Shares outstanding (eoy) m7.77804.51 1.0%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.03.0 33.4%   
Avg P/E ratio x33.342.0 79.4%  
P/CF ratio (eoy) x26.518.4 144.0%  
Price / Book Value ratio x3.93.5 111.3%  
Dividend payout %25.115.5 161.4%   
Avg Mkt Cap Rs m4,127434,516 0.9%   
No. of employees `0001.723.0 7.4%   
Total wages/salary Rs m60726,338 2.3%   
Avg. sales/employee Rs Th2,436.76,349.1 38.4%   
Avg. wages/employee Rs Th355.21,143.0 31.1%   
Avg. net profit/employee Rs Th72.5449.3 16.1%   
INCOME DATA
Net Sales Rs m4,162146,302 2.8%  
Other income Rs m612,287 2.7%   
Total revenues Rs m4,223148,589 2.8%   
Gross profit Rs m19724,758 0.8%  
Depreciation Rs m3213,229 0.2%   
Interest Rs m301,594 1.9%   
Profit before tax Rs m19712,222 1.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-70 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m731,798 4.0%   
Profit after tax Rs m12410,354 1.2%  
Gross profit margin %4.716.9 28.0%  
Effective tax rate %37.014.7 251.6%   
Net profit margin %3.07.1 42.1%  
BALANCE SHEET DATA
Current assets Rs m1,62987,370 1.9%   
Current liabilities Rs m1,05833,081 3.2%   
Net working cap to sales %13.737.1 37.0%  
Current ratio x1.52.6 58.3%  
Inventory Days Days3087 34.2%  
Debtors Days Days3462 53.9%  
Net fixed assets Rs m556111,567 0.5%   
Share capital Rs m781,609 4.8%   
"Free" reserves Rs m878123,645 0.7%   
Net worth Rs m1,069125,254 0.9%   
Long term debt Rs m15936,454 0.4%   
Total assets Rs m2,399209,532 1.1%  
Interest coverage x7.68.7 87.4%   
Debt to equity ratio x0.10.3 51.0%  
Sales to assets ratio x1.70.7 248.4%   
Return on assets %6.45.7 112.4%  
Return on equity %11.68.3 140.2%  
Return on capital %18.58.5 217.1%  
Exports to sales %0.834.2 2.3%   
Imports to sales %1.48.3 16.8%   
Exports (fob) Rs m3350,050 0.1%   
Imports (cif) Rs m5812,203 0.5%   
Fx inflow Rs m3351,066 0.1%   
Fx outflow Rs m6317,678 0.4%   
Net fx Rs m-3033,388 -0.1%   
CASH FLOW
From Operations Rs m12723,824 0.5%  
From Investments Rs m-146-13,127 1.1%  
From Financial Activity Rs m22-13,239 -0.2%  
Net Cashflow Rs m3-2,478 -0.1%  

Share Holding

Indian Promoters % 65.4 16.0 408.8%  
Foreign collaborators % 0.0 20.8 -  
Indian inst/Mut Fund % 3.7 12.2 30.3%  
FIIs % 5.2 23.7 21.9%  
ADR/GDR % 0.0 1.1 -  
Free float % 25.8 26.2 98.5%  
Shareholders   12,723 161,166 7.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   ORCHID PHARMA LTD  STERLING BIOTECH  ASTRAZENECA PHARMA  VENUS REMEDIES  IPCA LABS  

Compare TTK HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; IT Stocks Witness Losses(11:30 am)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the IT sector and power sector witnessing maximum selling pressure.

Related Views on News

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Cipla: Weak Quarter, Positive Triggers Ahead (Quarterly Results Update - Detailed)

Sep 19, 2016

Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Aug 21, 2017 01:07 PM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS